Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tom Hillary"'
Autor:
Marie Vangilbergen, MD, Aline Stockman, MD, Axelle Van De Velde, MD, Maria Garmyn, MD, PhD, Kevin Punie, MD, PhD, Tom Hillary, MD, PhD
Publikováno v:
JAAD International, Vol 17, Iss , Pp 71-79 (2024)
Background: Biologicals targeting interleukin (IL)-17 and IL-23 improve quality of life in psoriasis and other chronic autoimmune disorders with a favorable safety profile. However, current guidelines do not recommend their use in patients with recen
Externí odkaz:
https://doaj.org/article/f23ede736c2043cc95700499955f7fc5
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 547-564 (2024)
Abstract Background Psoriasis, a common chronic inflammatory skin disease with major impact on quality of life, is associated with several comorbidities. A better understanding of the pathogenesis of psoriasis has led to the development and approval
Externí odkaz:
https://doaj.org/article/08fc66fd6dfa49bebc68b3e59ddcb913
Autor:
Alvaro Gonzalez-Cantero, MD, PhD, María Magdalena Constantin, MD, Annunziata Dattola, MD, Tom Hillary, MD, Elise Kleyn, MD, PhD, Nina Magnolo, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 9, Iss 4, p e112 (2023)
Background:. The prevalence of psoriasis is similar between men and women; however, evidence exists of sex- and gender-related differences in disease expression, impact, coping, and needs of patients with psoriasis. These differences are essential an
Externí odkaz:
https://doaj.org/article/fd0c5521cdac4b1886894770d9a8ba1f
Autor:
Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, Elizaveta Padalko, Triana Lobaton, Séverine Vermeire
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe risks and impact of COVID19 disease and vaccination in patients with Immune Mediated Inflammatory Diseases (IMID) remain incompletely understood. IMID patients and particularly patients receiving immunosuppressive treatment were exclude
Externí odkaz:
https://doaj.org/article/99456f9e284e4ed789c888338138e551
Autor:
Tom Hillary, Jolien Clijmans, Séverine Vermeire, Jo Lambert, Marjan Garmyn, Maya Imbrechts, Thomas Vanassche
Publikováno v:
Annals of Medicine, Vol 53, Iss 1, Pp 1076-1083 (2021)
AbstractBackground Psoriasis is a chronic inflammatory skin disease associated with numerous comorbidities. Psoriasis has been linked to an increased risk of metabolic syndrome and atherosclerotic arterial disease. Inflammatory conditions are known t
Externí odkaz:
https://doaj.org/article/d852f241b97748eb8200709b3ffa876e
Autor:
Pierre-Dominique Ghislain, Jo Lambert, Xuãn-Lan Lam Hoai, Tom Hillary, Pierre-Paul Roquet-Gravy, Michel de la Brassinne, Siegfried Segaert
Publikováno v:
Advances in Therapy.
Autor:
Eveline De Brandt, Tom Hillary
Publikováno v:
Psoriasis: Targets and Therapy. 12:113-126
PURPOSE: To review the literature on guidance on the follow-up of psoriasis and its comorbidities and to provide practical recommendations. PATIENTS AND METHODS: A PubMed search was conducted using MeSH terms and free text keywords related to "psoria
Autor:
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, María Julia Cura, Maria Esposito, Anthony P. Fernandez, Paolo Gisondi, Alessandro Giunta, Tom Hillary, Stefano Piaserico, James A. Solomon, Joseph F. Merola
ObjectiveOur aim was to summarize and evaluate the current quality of evidence regarding the efficacy of therapies for cutaneous psoriasis (PsO) in patients with psoriatic arthritis (PsA).MethodsA literature search of MEDLINE, Embase, Cochrane Librar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3245ece69d3c98d87d11e31e1bf1d02a
https://hdl.handle.net/11562/1094490
https://hdl.handle.net/11562/1094490
Autor:
Julien Lambert, Tom Hillary, Pierre-Dominique Ghislain, Jo Lambert, Reinhart Speeckaert, Arjen Nikkels, F. Willaert, Siegfried Segaert
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 8, p. 1654-1665 (2020)
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 8, p. 1654-1665 (2020)
BACKGROUND: Impressive progress in new therapeutic options has been made for psoriasis. Treatments include topical steroids, phototherapy, conventional, synthetic disease-modifying drugs and an expanding list of biologics. OBJECTIVE: The primary obje
Publikováno v:
Archives of Clinical and Medical Case Reports.